A kiss of death for prostate cancer
Hokkaido University researchers have uncovered a cellular protein that stabilizes a tumor promoting signaling pathway, suggesting a new target to treat prostate cancer. The drug...
Hokkaido University researchers have uncovered a cellular protein that stabilizes a tumor promoting signaling pathway, suggesting a new target to treat prostate cancer. The drug...
MADISON, Wisconsin -- A new study by University of Wisconsin-Madison researchers identified the structural basis for how tightly bound protein complexes are broken apart to...
A new marker that could be used to diagnose fatal breast cancer up to one year ahead of current methods has been described in a...
BLOOMINGTON, Ind. -- The Affordable Care Act led to an increase in the number of cancer diagnoses -- particularly those at early stages -- in...
Researchers at the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus and the Colorado School of Mines received a two-year...
Credit: Baylor College of Medicine For breast cancer, carrying protein CD44s, instead of CD44v, has a survival advantage. Researchers have now discovered a mechanism by...
LA JOLLA--(December 21, 2017) Like an actor who excels at both comedy and drama, proteins also can play multiple roles. Uncovering these varied talents can...
Individual tumors respond differently to cancer drugs, if at all. Until now, it remained a mystery why tumors have different reactions to the exact same...
Credit: Stacey D. Finley, Ph.D. Using a mathematical modeling approach, scientists have found that certain parameters of tumor growth in mice can predict the effectiveness...
Oncotarget, a distinguished multidisciplinary bio-medical journal, reassured readers this week that all of its scientific publications are and will continue to be available on PubMed,...
As advancements in cancer therapies have been making headlines in recent years, cancer drug prices have significantly increased. The remaining question is, what are the...
Credit: Eric Smith and Christopher Garcia By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two...
Credit: Delfim Duarte/Imperial College London Chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used to treat an unrelated...
Colorectal cancer is the most prevalent malignant tumour in Spain. It is known that factors such as diet and intestinal inflammation play an important role...
New Orleans, LA - Using data interpreted by LSU Health New Orleans' Louisiana Tumor Registry, a case-control study found for the first time that older...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.